πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,301 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7253341

Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucle

Fulcrum SP Ltd. Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7247751

Processes for preparing cinacalcet hydrochloride crystal Form I

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7244844

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7235691

Crystalline forms of modafinil

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7223424

Compositions and methods for prostate and kidney health and disorders, an herbal preparati

Integrated Chinese Medicine Holdings Ltd. Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7196222

Sertraline hydrochloride form II and methods for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7195778

Drug delivery system for zero order, zero order-biphasic, ascending or descending drug del

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7192588

Vaccine composition and method of using the same

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7189706

C2,5β€²-disubstituted and N6,C2,5β€²-trisubstituted adenosine derivatives and pharmaceutical c

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7189861

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7183272

Crystal forms of oxcarbazepine and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7173062

Method for the improvement of skin wrinkles using retinyl retinoate

ENPRANI CO., LTD. Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7161012

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7151183

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7148376

Polymorphic forms of nateglinide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7144720

Protein and DNA thereof

Takeda Chemical Industries Ltd. Β· Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7144916

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141553

A3AR agonists for the treatment of inflammatory arthritis

Can-Fite Biopharma Ltd. Israel Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7138137

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparatio

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7129358

Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7126008

Carvedilol

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122681

Desolvation process for the production of atorvastatin hemi-calcium essentially free of bo

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7112574

C2,8-disubstituted adenosine derivatives and their different uses

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7098364

Phenylethanolamine compounds as Ξ²2-receptor agonists, and methods of use and preparation t

Jinzhou Jiutai Pharmaceutical Co., Ltd., China Β· Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted